| Estimated prevalence of opioid use disorder in Massachusetts, 2011–2015: a capture–recapture analysis JA Barocas, LF White, J Wang, AY Walley, MR LaRochelle, D Bernson, ... American Journal of Public Health 108 (12), 1675-1681, 2018 | 152 | 2018 |
| Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths JA Barocas, J Wang, BDL Marshall, MR LaRochelle, A Bettano, ... Drug and alcohol dependence 200, 59-63, 2019 | 131 | 2019 |
| Population-level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States JA Barocas, A Tasillo, G Eftekhari Yazdi, J Wang, C Vellozzi, S Hariri, ... Clinical Infectious Diseases 67 (4), 549-556, 2018 | 76 | 2018 |
| Whose story wins on twitter? Visualizing the South China Sea dispute L Guo, K Mays, J Wang Journalism Studies 20 (4), 563-584, 2019 | 56 | 2019 |
| Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis JA Barocas, JR Morgan, J Wang, D McLoone, A Wurcel, MD Stein Clinical Infectious Diseases 72 (3), 472-478, 2021 | 54 | 2021 |
| Projected Estimates of Opioid Mortality After Community-Level Interventions BP Linas, A Savinkina, RWMA Madushani, J Wang JAMA NETWORK OPEN, 2021 | 53 | 2021 |
| Hepatitis C testing increased among baby boomers following the 2012 change to CDC testing recommendations JA Barocas, J Wang, LF White, A Tasillo, JA Salomon, KA Freedberg, ... Health Affairs 36 (12), 2142-2150, 2017 | 44 | 2017 |
| Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons SA Assoumou, A Tasillo, C Vellozzi, G Eftekhari Yazdi, J Wang, S Nolen, ... Clinical Infectious Diseases 70 (7), 1388-1396, 2020 | 39 | 2020 |
| Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset JM Freiman, J Wang, PJ Easterbrook, CR Horsburgh, F Marinucci, ... Journal of hepatology 71 (1), 62-70, 2019 | 22 | 2019 |
| Opioid overdose and inpatient care for substance use disorder care in Massachusetts JR Morgan, J Wang, JA Barocas, JL Jaeger, NN Durham, ... Journal of substance abuse treatment 112, 42-48, 2020 | 20 | 2020 |
| HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic SA Assoumou, J Wang, S Nolen, G Eftekhari Yazdi, KH Mayer, J Puro, ... Journal of general internal medicine 35, 1477-1483, 2020 | 17 | 2020 |
| HIV pre-exposure prophylaxis and buprenorphine at a drug detoxification center during the opioid epidemic: opportunities and challenges SA Assoumou, SM Paniagua, P Gonzalez, J Wang, CG Beckwith, ... AIDS and Behavior 25, 2591-2598, 2021 | 15 | 2021 |
| Hepatitis C virus antibody testing among 13-to 21-year-olds in a large sample of US federally qualified health centers RL Epstein, J Wang, L Hagan, KH Mayer, J Puro, BP Linas, SA Assoumou JAMA 322 (22), 2245-2248, 2019 | 15 | 2019 |
| The prevalence of opioid use disorder in Kentucky’s counties: A two-year multi-sample capture-recapture analysis K Thompson, JA Barocas, C Delcher, J Bae, L Hammerslag, J Wang, ... Drug and alcohol dependence 242, 109710, 2023 | 13 | 2023 |
| Rapid versus laboratory-based testing for HIV and hepatitis C at a drug detoxification treatment center: a randomized trial SA Assoumou, SM Paniagua, BP Linas, J Wang, JH Samet, J Hall, ... The Journal of infectious diseases 222 (Supplement_5), S376-S383, 2020 | 11 | 2020 |
| Factors associated with opioid-involved overdose among previously incarcerated people in the US: a community engaged narrative review JM Flam-Ross, J Lown, P Patil, LF White, J Wang, A Perry, D Bailer, ... International Journal of Drug Policy 100, 103534, 2022 | 9 | 2022 |
| Hepatitis C testing and patient characteristics in Washington State's prisons between 2012 and 2016 SA Assoumou, J Wang, A Tasillo, GE Yazdi, JI Tsui, L Strick, BP Linas American journal of preventive medicine 56 (1), 8-16, 2019 | 9 | 2019 |
| The burden of untreated HCV infection in hospitalized inmates: a hospital utilization and cost analysis AG Wurcel, DJ Burke, JJ Wang, B Engle, K Noonan, TA Knox, AY Kim, ... Journal of Urban Health 95, 467-473, 2018 | 7 | 2018 |
| Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs JW Adams, A Savinkina, A Fox, CN Behrends, RWMA Madushani, ... Addiction 117 (10), 2635-2648, 2022 | 6 | 2022 |
| Medicaid hepatitis C virus treatment policies: impact on testing and treatment in the commercially insured RL Epstein, J Wang, LF White, SN Kapadia, JR Morgan, Y Bao, BP Linas American journal of preventive medicine 63 (3), e87-e98, 2022 | 6 | 2022 |
Benjamin P LinasBoston University在 bmc.org 的电子邮件经过验证
